Insiders Trades
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (29 ops.)
Latest filing published 10 Sept 2026 for Cullinan Therapeutics, Inc., €15k. Read the official filing
Filing timeline
BuySaleJennifer Michaelson
Insider track record
Disclosed buys
0
Disclosed sells
29
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Jennifer Michaelson: trading record in brief
Jennifer Michaelson is a declared insider of Cullinan Therapeutics, Inc. (chief executive), with filings sourced from SEC (Form 4). In total, 50 filings cover trades dated from 18 August 2021 to 8 September 2026.
Every open-market trade on record is a sale: 29 sales worth €1.6M. The rest of the record consists of 7 share grants and 14 option exercises. In 2026 alone, the filings show no purchases and 8 sales.
The record was last updated on 10 September 2026 with an option exercise (€15k) in Cullinan Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Jennifer Michaelson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations50 total
4,000 shares@ US$4.30Common StockSEC:0001193125-26-387381:0
8,000 shares@ US$21.57Common StockSEC:0001193125-26-387381:1
30,000 shares@ US$20.260.050% mcap29.6% of flowCommon StockSEC:0001193125-26-352523:1
30,000 shares@ US$4.300.011% mcap6.3% of flowCommon StockSEC:0001193125-26-352523:0
4,000 shares@ US$4.300.0014% mcap1.7% of flowCommon StockSEC:0001193125-26-297605:0
8,000 shares@ US$17.820.012% mcap13.9% of flowCommon StockSEC:0001193125-26-297605:1
4,000 shares@ US$4.301.3% of flowCommon StockSEC:0001193125-26-098781:0
1,780 shares@ US$14.141.9% of flowCommon StockSEC:0001193125-26-077259:0
1,752 shares@ US$13.991.8% of flowCommon StockSEC:0001193125-26-072002:0
3,742 shares@ US$13.623.8% of flowCommon StockSEC:0001193125-26-064256:0
57,500 shares0Common StockSEC:0001193125-26-059636:0
416 shares@ US$12.030.4% of flowCommon StockSEC:0001193125-26-051700:0
4,000 shares@ US$12.303.7% of flowCommon StockSEC:0001193125-26-021225:0
1,345 shares@ US$10.011.2% of flowCommon StockSEC:0001193125-25-328909:0
2,898 shares@ US$9.672.4% of flowCommon StockSEC:0001193125-25-327027:0
2,148 shares@ US$12.382.4% of flowCommon StockSEC:0001193125-25-321122:0
4,000 shares@ US$12.304.5% of flowCommon StockSEC:0001193125-25-297549:0
3,756 shares@ US$8.534.0% of flowCommon StockSEC:0000950170-25-029200:0
50,000 shares0Common StockSEC:0000950170-25-025032:0
4,000 shares@ US$12.516.4% of flowCommon StockSEC:0000950170-25-002946:0
4,693 shares@ US$11.416.7% of flowCommon StockSEC:0000950170-24-139125:0
3,489 shares@ US$12.525.5% of flowCommon StockSEC:0000950170-24-136726:0
8,000 shares@ US$15.6415.2% of flowCommon StockSEC:0000950170-24-123538:0
8,000 shares@ US$18.0917.2% of flowCommon StockSEC:0000950170-24-104820:0
8,000 shares@ US$16.3316.0% of flowCommon StockSEC:0000950170-24-082485:0
25 of 50 declarations
